News

MADISON, Wis.--(BUSINESS WIRE)--Gentel Biosciences, a leader in proteomics discovery tools, today launched the Gentel Proteomics Multi-System™ providing "scan-to-analysis" functionality for multiplex immunoassays, lysate and antigen arrays as well as Western Blot, ELISA and tissue imaging, delivering multi-application value to researchers worldwide.

Gentel's pleased to announce the immediate availability of our newest chromogenic-based assay kits, the 17-plex, quantitative APiX Human Cytokine Kit and the 12-plex, quantitative APiX Murine Cytokine Kit.

These comprehensive, cost-effective kits measure cytokine levels in either human or mouse serum respectively and are compatible with the APiX GR8 Scanning System.

MADISON, Wis. - Gentel Biosciences, Inc., a leading protein microarray technologies firm, announced today the availability of its APiX™ Chromogenic Protein Array System to the global research community. Composed of a user friendly scanner with optional analysis software, proprietary surface chemistry substrates, and licensed detection reagents, it offers an affordable and ultra-sensitive alternative to current fluorescent protein microarray platforms.

MADISON, WI— Gentel Biosciences, an acknowledged leader in protein microarray technology, announced it has been invited to join a collaborative Clinical Research and Development consortium using novel technologies developed by the company to gain insight into major diseases of pregnancy.

MADISON, Wis. - Gentel Biosciences, a protein microarray life sciences company, announces a technology partnership with Eprogen to create products for the discovery of new autoantibody biomarkers using whole proteome microarrays.

MADISON, Wis. - Gentel Biosciences announces the promotion of G. Randall Durnell, Ph.D., to Executive Vice President & Chief Operating Officer and the hiring of Dan Clutter, Ph.D., as Vice President of Commercial Development.

MADISON, WI & Cape Town, RSA - Gentel Biosciences, Inc., a protein microarray life sciences company, announces it has placed its first APiX™ Colorimetric Protein Array Reader at the Centre for Proteomic and Genomic Research (CPGR) in Cape Town, South Africa.

MADISON, WI - Gentel® Biosciences, a protein microarray life sciences company, announces it has obtained an exclusive license to novel technology for manufacturing highly-reproducible nitrocellulose protein microarray slides.

The technology, developed by Agnitio Science and Technology of Hsinchu, Taiwan, covers the use of ultrasonic coating to produce nitrocellulose films. “Ultrasonic coating produces nitrocellulose films with a consistency unattainable using traditional coating processes like casting,” stated Dr. Bryce Nelson, Gentel’s VP of Research and Development. “Additionally, the technology is extremely flexible and can be used to fabricate optically clear or porous white nitrocellulose films.”

MADISON, WI (June 1, 2008) — Gentel® Biosciences, a leader in protein microarrays, today announced it has signed a global license agreement with Eppendorf AG, Hamburg Germany, to provide Gentel’s customers with an ultra-sensitive multiplexed protein analysis tools using colorimetric detection and its proprietary nitrocellulose films.

The agreement licenses Eppendorf’s Silverquant® colorimetric detection technology for use in protein detection assays. Silverquant is a patented method in which gold particle-enhanced silver crystal deposition is used for detection and quantification on microarrays.

MADISON, WI— Gentel® Biosciences, a protein microarray life sciences company, has expanded the Custom Services organization beginning with an initial investment in multiple Tecan automated systems to meet the growing demands in sample testing and custom assay development for multipex protein measurements.

Gentel is in the process of making substantial investments in additional instrumentation to aggressively expand the capacity of the company in direct response to ongoing and new client contracts. The additional equipment has enabled Gentel to automate and process thousands more samples per day for its growing list of clients, including a number of biotechnology companies and academic research centers.